Abiopharma

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects

Propanc Biopharma Provides Shareholder Update

Biofrontera Notification (BFRI)

IDEXX Announces CEO Succession

EPAM Systems, Inc. - EPAM to Host Investor Day on March 12, 2026

Ginkgo Bioworks - Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Edgewise Therapeutics - Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026

Omnicell - Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026